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A B ST R AC T  
 
Aim: Pregnancy rhinitis (PR) is characterized with nasal symptoms during pregnancy without any signs of 
respiratory infection and it usually disappears within 2 weeks after delivery. We aimed to investigate the 
relationship between pregnancy rhinitis and findings derived from anterior rhinoscopy (AnR), anterior 
rhinomanometry (ARM) and subjective nasal obstruction score (SNOS).  
Methods: This prospective, controlled study was performed in otorhinolaryngology and obstetrics and 
gynecology departments of our tertiary care center. A total of 30 pregnant women in the third trimester and 30 
non-pregnant women were involved. All participants underwent otorhinolaryngology examination, as well as 
clinical evaluation for AnR, ARM and SNOS.  
Results: Pregnancy rhinitis was detected in 66.7% of the pregnant women. The mean AnR was 3.60 ± 1.35 in 
pregnant women and 0.77 ± 0.73 in the control group. Total nasal inspiratory resistance (TNID) was 0.46±0.23 
in pregnant women and 0.27±0.06 in the control group. The mean SNOS was 1.37±0.72 in pregnant women 
and 0.57±0.63 in the control group. AnR, ARM and SNOS findings were significantly higher in pregnant 
women (p<0.05). There is a low positive and significant correlation between AnR, ARM, and SNOS values 
in pregnant women (p<0.05). 
Conclusion: Our data yielded that nasal obstruction and pregnancy rhinitis were common in pregnant women.  
Nasal symptoms and complaints must be carefully examined during pregnancy. Further prospective, 
controlled, randomized trials on larger series are warranted to elucidate the clinical and pathophysiological 
features of pregnancy rhinitis. 
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Introduction 
Pregnancy rhinitis (PR) is defined as the 
presence of nasal symptoms occurring only 
during pregnancy for more than six weeks 
without any known allergic cause and no signs 
of respiratory infection. These symptoms 
disappear in the first two weeks after delivery. 
PR occurs in 20-30% of women between the 3- 
7 months of pregnancy [1, 2]. The 
pathophysiological mechanism causing 
pregnancy rhinitis is that vasomotor imbalance 
in the nasal mucosa due to changes in estrogen 
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and progesterone levels causes hyperemia and 
edema in the nasal mucosa. Also, placental 
growth hormone was found to be high in 
pregnancy rhinitis [3, 4].  
Rhinitis does not directly affect pregnancy. 
However, uncontrolled rhinitis can increase 
stress by indirectly disturbing the nutritional 
and sleep status of the pregnant woman. 
Pregnancy hypertension, low Apgar score, 
preeclampsia and intrauterine growth 
retardation may be encountered due to rhinitis 
induced snoring [5, 6]. Control of rhinitis 
during pregnancy reduces the risk of additional 
medication by increasing the quality of life of 
pregnant women [7, 8].  
We aimed to investigate the frequency of 
pregnancy rhinitis and seek whether there is a 
correlation between anterior rhinoscopy (AnR) 
findings, anterior rhinomanometry (ARM) 
measurements, and subjective nasal obstruction 
scores (SNOS). 
 
Materials and Methods 
This prospective study was carried out by the 
otorhinolaryngology and obstetrics & 
gynecology clinics of our institution. The study 
was approved by the local ethics committee and 
consent was obtained from all the participants 
(2017/73). A total of 30 pregnant women aged 
between 19-35 years who were in the third 
trimester of pregnancy were recruited. The 
control group included 30 non-pregnant 
women. The participant women had no history 
of allergic rhinitis (AR), septal deviation, and 
signs of acute or chronic upper respiratory tract 
infections, non-allergic rhinitis, nasal polyps, 
and sinonasal tumors.  
Outcome parameters 
A complete otorhinolaryngologic examination 
and decongestant-free active anterior 
rhinomanometry (ARM) were performed 
routinely for all participants.  
All examinations and tests were performed 
between 27th and 40th weeks of pregnancy. In 
the history, pregnant women were asked to 
score the level of nasal congestion as for SNOS 
(none=0, mild=1, moderate=2, severe=3, fully 
blocked=4).  
In the first examination, nulliparous women 
were asked whether they had PRs in the first 
and second trimesters. Multiparous women 
were asked whether they had PR in the previous 
pregnancies or during the current pregnancy. 
The gender of the baby was noted and pregnant 
women were asked to describe the nasal 
obstruction during pregnancy as either 
“increased”, “decreased” or “unchanged”. 
In endoscopic examination, turbinate 
hypertrophy in a nasal cavity was scored by 1-
point, the mild congestion of the mucosa was 
scored as 1 point and severe congestion was 
scored as 2-points. Therefore, the highest score 
a pregnant can get in anterior rhinoscopic 
examination was 6 points [9]. 
Decongestant-free ARM was performed on all 
pregnant women by using Rhinostream SRE 
2000 (Interacoustics A/S, Drejervaenget 8, DK-
5610 Assens, and Denmark) rhinomanometry 
device. The mask covered both the mouth and 
the nose. The pressure probe passed through the 
mask was placed in a nostril and the nasal flow 
probe in the other nostril. During placement of 
the probes, attention was paid not to deform the 
nostrils and to prevent the air leakage. Pregnant 
women were asked to keep their mouths closed 
and breathe through their noses. The values 
were read at 150 Pa. After expiration and 
inspiration, nasal resistance was recorded in 
Pa/cm3 and the individual resistances of each 
nostril and the total inspiratory nasal resistance 
were calculated. Patients who had nose 
clearance before ARM had rested for 20 
minutes in a room with a temperature of 20±3 
℃, the humidity was 50%, and the illumination 
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was moderate. The patients were instructed 
about the test. They had not exercised for 2 
hours preceding the test and they were asked 
not to have tea, coffee, and cigarettes.  
Results from the pregnant group were 
compared with 30 non-pregnant women in the 
control group who were non-smokers and did 
not have any signs of acute upper respiratory 
tract infections, or chronic sinonasal diseases. 
Thus, AnR, ARM and SNOS scores were 
recorded under same conditions. 
Statistical analysis 
Statistical analysis was performed by using 
SPSS 24.0 software (Statistical Package for 
Social Sciences Inc., Chicago, IL, USA). In 
terms of descriptive statistical methods, Mann 
Whitney U test for difference tests and 
Spearman Brown test for correlation were used 
since the data displayed non-parametric 
features. The results were evaluated with a 
confidence interval of 95% and a p-value less 




The mean ages in the study and control groups 
were 30.43±3.65 and 30.37±4.07, respectively. 
The gestational age during examination ranged 
between 27 and 39 weeks (mean: 34.2±3.71; 
median: 36). Of the 30 pregnant women, 9 
(30%) were nulliparous and 21 (70%) were 
multiparous. A total of 16 newborns were male 
(53.3%) and 14 (46.7%) were female. 
None of the pregnant women reported any relief 
of nasal congestion during pregnancy. The 
complaints did not change in 11 women 
(36.7%) and were increased in 19 women 
(63.3%). Fifteen of 21 multiparous women 
(71.4%) reported absence of PR, while 6 
(28.6%) of them reported presence of PR in 
their previous pregnancies. In their current 
pregnancies, no PR were diagnosed in 10 
pregnant women (33.3%), while PR was 
diagnosed in 20 pregnant women (66.7%) 
(Table 1). 
 
Table 1. Gestational features and rhinitis 
















The mean ANR values in the study and control 
groups were 3.60±1.35 and 0.77±0.73, 
respectively. Therefore, pregnant women 
exhibited higher AnR scores compared to non-
pregnant women. 
Regarding ARM findings, the mean total nasal 
inspiratory resistance (TNID) was 0.46±0.23 in 
the study group and 0.27±0.06 in the control 
group. The minimum and mode TNID scores 
were similar between 2 groups (0.19 and 0.18; 
0.24 and 0.23). However, the maximum TNID 
was 0.39 in the control group and 1.07 in the 
study group. Therefore, the average TNID score 
was higher in pregnant women. Moreover, 
TNID values were grouped according to 0.12-
0.33 Pa/ml/s, which was accepted as the normal 
value range in rhinomanometric measurements. 
With reference to this threshold, 9 (30%) of 
pregnant women in the study group and 25 
(83.3%) of the non-pregnant women in the 




Average pregnancy weeks 34.2±3.71 
Median pregnancy weeks 36 
Nulliparous 30% (n=9) 
Multiparous 70% (n=21) 
Nasal congestion decreased 0% (n=0) 
Nasal congestion unchanged 36.7% (n=11) 
Nasal congestion increased 63.3% (n=19) 
Presence of rhinitis 66.7% (n=20) 
Absence of rhinitis 33.3% (n=10) 
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On the other hand, the mean SNOS in the study 
and control groups were 1.37±0.72 and 
0.57±0.63, respectively. We noted that SNOS 
averages of pregnant women were significantly 
higher than non-pregnant women (Table 2). 
The analysis of descriptive findings yielded that 
AnR, ARM and SNOS displayed significant 
differences between study and control groups 
(p<0.05). AnR, ARM and SNOS findings of in 
pregnant women were significantly higher than 
































In the study group, the correlation between 
AnR, ARM and SNOS was sought and the 
correlation between AnR and ARM was 0.176. 
The correlation between AnR and SNOS was 
0.295 and the correlation between ARM and 
SNOS was 0.197. These correlations were 
found to be low and positive, but they were 
significant (p<0.05). 
As for these results, if any of AnR, ARM and 
SNOS values of the pregnant women increased, 
the others also tended to increase mildly. The 
Table 2. AnR, ARM and SNOS results in the study and control groups. 
Groups Minimum Maximum Average Median Mode 
Study group 
    AnR 
    ARM 
    SNOS 
0 6 3.60±1.35 4 4 
0.19 1.07 0.46±0.23 0.39 0.24 
0-none 3-severe 1.37±0.72 1-mild 1-mild 
Control group 
    AnR 0 2 0.77±0.73 1 1 
    ARM 0.18 0.39 0.27±0.06 0.25 0.23 
    SNOS 0-none 2-moderate 0.57±0.63 0.50-mild 0-none 
[Abbreviations: *Anterior rhinoscopy (AnR), anterior rhinomanometry (ARM) and subjective nasal 
obstruction score (SNOS)]. 
 




𝒙 Ave. Row Rows Total U Z p-value* 
AnR 
Study  3.60 44.20 1326.00 
39.000 -6.200 <0.00 
Control  0.77 16.80 504.00 
ARM 
Study  0.46 40 1200.00 
165.000 -4.219 <0.00 
Control 0.27 21 630.00 
SNOS 
Study 1.37 38.88 1166.50 
198.500 -4.042 <0.00 
Control 0.57 22.12 663.50 
* Mann-Whitney U Test. [Abbreviations: **Anterior rhinoscopy (AnR), anterior rhinomanometry 
(ARM) and subjective nasal obstruction score (SNOS)]. 
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determination coefficient (explained 
variance=r2) was calculated to determine the 
impact of changes of AnR, ARM and SNOS 
measurements on the other. As a result, r2 value 
between AnR and ARM was found to be 3.1. 
This value was 8.7 between AnR and SNOS; 
and it was 3.8 between ARM and SNOS. Any 
changes in AnR or ARM constitutes an 
alteration of 3.1%. In the other parameters, 
these percentages were found to be 8.7% and 
3.8%. 
Furthermore, the regression equation between 
AnR and SNOS was y=0.6+0.21x. It was 
y=1.16+0.46x between ARM and SNOS, and 
y=0.39+0.02x between AnR and ARM.   
In the control group, the correlation was 0.134 
between AnR and ARM, 0.131 between AnR 
and SNOS and -0.36 between ARM and SNOS. 
Therefore, the correlations between AnR-ARM 
and AnR-SNOS were low and positive. 
However, the relationship between ARM and 
SNOS was very low and negative.  
As for these results, r2 between AnR and ARM 
was 1.8, r2 between AnR and SNOS was 1.7, 
and r2 between ARM and SNOS was 0.1. These 
findings may be interpreted as any change in 
AnR or ARM constitutes 1.8% change. In the 




In the present study, the prevalence of PR was 
66.7% and it was reported as 40% in previous 
publications [10]. The nasal obstruction 
symptom evaluation (NOSE) scores in the 
study and control groups displayed no 
significant differences (p = 0.866). Minimal 
cross sectional areas at internal nasal valve and 
at the level of the head of inferior turbinate 
decreased significantly between the first and 
third trimesters (2). There was no difference 
between the trimesters as for 
total nasal resistance. The correlation analysis 
between the NOSE score, total volume and 
minimal cross sectional area at internal nasal 
valve demonstrated no significant differences 
[11]. 
In Sweden, the prevalence of PR was found to 
be 22% in a series of 599 patients [12]. Thus, it 
is possible to say that the global prevalence is 
considerably higher than the prevalence in 
Turkey. However, relatively larger samples 
should be studied for achievement of more 
objective outcomes. 
We noted that nasal obstruction and PR were 
common during pregnancy. The previous PR 
was found in 28.6% of multiparous 
pregnancies. The presence of rhinitis in the 
current pregnancy was detected as 66.7%. The 
mean AnR score was 3.60±1.35. Our results 
were close to the value of 3.47 reported by 
Philpott et al. [13]. The utilities of AnR and 
ARM has been recommended for evaluation of 
rhinitis and nasal physiological changes during 
pregnancy [13]. Subjective nasal obstruction 
scale (SNOS) has been validated as a reliable 
tool of nasal congestion in previous studies 
[14]. 
Ülkümen et al. [15] reported that an incidence 
of 38.89% for PR. Nasal congestion was 
significantly associated with body-mass index 
and gestational weeks. Patients should be 
informed about adverse fetal and maternal 
outcomes of pregnancy related nasal congestion 
which may be aggravated by obesity and 
excessive weight gain during pregnancy. 
In our study, the mean ARM was 0.46±0.23 and 
the mean SNOS was 1.37±0.72. The 
correlations between AnR-ARM, ARM-SNOS 
and AnR-SNOS were 0.176, 0.195 and 0.295, 
respectively.   
The nasal obstruction associated with PR may 
lead to with diminution of the quality of life and 
sleep [16]. Gilbey et al. [17] suggested that 
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rhinosinusitis-specific quality of life was lower 
in the third trimester compared to that of the 
second trimester and that of patients without 
rhinosinusitis. Thus, increased awareness is 
important to improve the quality of life in 
pregnant women, prevent sleep apnea and 
related morbidity, and positively affect the 
gestational outcomes. There is controversy on 
the influence of atopy on the pregnancy 
outcomes since some authors postulated that 
atopy may be associated with more favorable 
results [17]; whereas some publications 
indicated that there was no link between atopy 
and recurrent abortions [18,19]. 
The main limitations of our study include 
relatively small sample size, subjectivity of 
detection of SNOS and data limited to the 
experience of a single center. On the other hand, 
prospective design and integrity of specific data 
constituted the strengths of our study.  
 
Conclusions 
To conclude, nasal obstruction and PR are 
common conditions in pregnant women. As 
reflected in higher scores of AnR, ARM and 
SNOS values, nasal symptoms and complaints 
must be questioned during follow-up in 
pregnancy. A low positive, but significant 
correlation was noted between AnR, ARM and 
SNOS measurements in pregnant women. The 
implementation of further multicentric trials on 
larger series may aid in accomplishment of 
more accurate results.  
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